P92 Quantifying the unmet need in lupus nephritis: EULAR/ERA- EDTA treatment targets, flares, and treatment modifications in the first year in a multicenter observational study
Main Authors: | Maria Tektonidou, George K Bertsias, Dimitrios T Boumpas, Antonis Fanouriakis, Prodromos Sidiropoulos, Petros P Sfikakis, Antigone Pieta, Dimitrios Vassilopoulos, Maria Pappa, Paraskevi V Voulgari, Theodoros Dimitroulas, Andreas Goules, Charalampos Papagoras, Christina Tsalapaki, Maria Kosmetatou, Flora Chouzouri, Evangelia Argyriou, Aglaia Chalkia, Mirto Cheila, Georgios Demirtzoglou, Christina Katsiari, Dimitrios Petras, Kyriaki Boki |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-03-01
|
Series: | Lupus Science and Medicine |
Similar Items
-
Attainment of EULAR/ERA-EDTA targets of therapy with current immunosuppressive regimens and adjustments in treatment: a multicentre, real-life observational study
by: Dimitrios T Boumpas, et al.
Published: (2024-09-01) -
Anxiety and depression severity in neuropsychiatric SLE are associated with perfusion and functional connectivity changes of the frontolimbic neural circuit: a resting-state f(unctional) MRI study
by: Efrosini Papadaki, et al.
Published: (2021-05-01) -
P100 Efficacy of anifrolumab in multi-refractory skin manifestations of systemic lupus erythematosus: case series
by: George Bertsias, et al.
Published: (2024-03-01) -
Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations
by: Dimitrios T Boumpas, et al.
Published: (2020-09-01) -
Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the Prospect of Their Inhibition with an Oral Agent
by: Alessia Alunno, et al.
Published: (2019-08-01)